A Phase 1 Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors

Conditions:   Breast Cancer;   Glioblastoma;   Head and Neck Squamous Cell Carcinoma;   Malignant Mesothelioma;   Non-small Cell Lung Cancers;   Sarcoma Intervention:   Drug: PRT3645 Sponsor:   Prelude Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials